Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Clermont-Ferrand cedex 1, France Clinical Trials

A listing of Clermont-Ferrand cedex 1, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris

Sepsis is a major cause of death in Intensive Care Units and therefore finding new therapies to improve survival rates and limit morbidity is a major goal. Over the past decades, blood purification has been proposed as an adjuvant therapy for sepsis. The goal of blood purification is to restore ...

Phase N/A

0.0 miles

Learn More »

Management of Paroxystic Atrial Fibrillation in French Intensive Care Units

Atrial fibrillation (AF) is a common arrhythmia in the ICU and is associated with significant morbidity. However, curative treatment remains unclearly established. In fact, there are no specific recommendations for new onset atrial fibrillation in ICU and only few studies have assessed this topic. The PAF-ICU trial is an observational, ...

Phase N/A

0.0 miles

Learn More »

Use of Pre-operative Global Longitudinal Strain to Predict Post-operative Left Ventricular Dysfunction in Mitral Regurgitation Surgery

Primary mitral regurgitation (MR) is the second most frequent valve disease requiring surgery. In these patients, mitral repair is associated with excellent outcomes in terms of post-operative left ventricular (LV) function, and long-term survival when performed before the onset of severe symptoms, LV dysfunction or dilatation, pulmonary hypertension, and atrial ...

Phase N/A

1.63 miles

Learn More »

Study of the Metrological Properties of Two Assessment Grids of the Driving Capacity After a Cerebrovascular Accident (ROADTRIP)

The patients will benefit a medical consultation to estimate the possibility of inclusion in the study. During this consultation, the results of the neuropsychological and ophthalmological examinations will be explored and a specificity of the sensitive-driving deficits presented by the patient will be estimated to recommend the arrangements of necessary ...

Phase N/A

1.63 miles

Learn More »